Bluejay Diagnostics shareholders approve reverse stock split of up to 1-for-20

Bluejay Diagnostics, Inc.

Re-elected directors Chase, N. Dey, S. Dey, Wurth, Zeidman to 2026 term.
Approved reverse stock split at 1-for-2 to 1-for-20 ratio; board may implement within one year.
Approved additional reverse split (same ratio) contingent on first split being executed.
Ratified Wolf & Company as independent auditor for FY 2025.
Record date May 15, 2025; 616,134 shares voted from 1,494,182 outstanding.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.